BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 20494704)

  • 1. Transarterial liver-directed therapies of neuroendocrine hepatic metastases.
    Nazario J; Gupta S
    Semin Oncol; 2010 Apr; 37(2):118-26. PubMed ID: 20494704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chemoperfusion and embolization in the treatment of liver metastases].
    Vogl TJ; Mack MG; Eichler K; Zangos S; Naguib NN; Gruber-Rouh T
    Rofo; 2011 Jan; 183(1):12-23. PubMed ID: 21113865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional hepatic chemotherapies in the treatment of colorectal cancer metastases to the liver.
    Pwint TP; Midgley R; Kerr DJ
    Semin Oncol; 2010 Apr; 37(2):149-59. PubMed ID: 20494707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transarterial chemoembolization, transarterial chemotherapy, and intra-arterial chemotherapy for hepatocellular carcinoma treatment.
    Tsochatzis EA; Germani G; Burroughs AK
    Semin Oncol; 2010 Apr; 37(2):89-93. PubMed ID: 20494700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Locoregional management of hepatic metastasis from primary uveal melanoma.
    Sato T
    Semin Oncol; 2010 Apr; 37(2):127-38. PubMed ID: 20494705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arterial therapies of colorectal cancer metastases to the liver.
    de Baere T; Deschamps F
    Abdom Imaging; 2011 Dec; 36(6):661-70. PubMed ID: 21681492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic-directed Therapies in Patients with Neuroendocrine Tumors.
    Kennedy AS
    Hematol Oncol Clin North Am; 2016 Feb; 30(1):193-207. PubMed ID: 26614377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroendocrine liver metastases.
    Reddy SK; Clary BM
    Surg Clin North Am; 2010 Aug; 90(4):853-61. PubMed ID: 20637952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver metastases of neuroendocrine carcinomas: interventional treatment via transarterial embolization, chemoembolization and thermal ablation.
    Vogl TJ; Naguib NN; Zangos S; Eichler K; Hedayati A; Nour-Eldin NE
    Eur J Radiol; 2009 Dec; 72(3):517-28. PubMed ID: 18829195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoembolization in patients at high risk: results and complications.
    Kiely JM; Rilling WS; Touzios JG; Hieb RA; Franco J; Saeian K; Quebbeman EJ; Pitt HA
    J Vasc Interv Radiol; 2006 Jan; 17(1):47-53. PubMed ID: 16415132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salvage therapy for liver-dominant colorectal metastatic adenocarcinoma: comparison between transcatheter arterial chemoembolization versus yttrium-90 radioembolization.
    Hong K; McBride JD; Georgiades CS; Reyes DK; Herman JM; Kamel IR; Geschwind JF
    J Vasc Interv Radiol; 2009 Mar; 20(3):360-7. PubMed ID: 19167245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transarterial chemoembolization is a safe treatment for unresectable hepatic malignancies.
    Lopez RR; Pan SH; Lois JF; McMonigle ME; Hoffman AL; Sher LS; Lugo D; Makowka L
    Am Surg; 1997 Oct; 63(10):923-6. PubMed ID: 9322674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicentric phase II clinical trial on intra-arterial hepatic radiotherapy with 90yttrium SIR-spheres in unresectable, colorectal liver metastases refractory to i.v. chemotherapy: preliminary results on toxicity and response rates.
    Mancini R; Carpanese L; Sciuto R; Pizzi G; Golfieri R; Giampalma L; Cappelli A; Galaverni MC; Blotta A; Fiore F; Izzo F; Lastoria S; Mastro A; Di Marzo M; Cagol PP; Gasparini D; Geatti O; Bacchetti S; Pasqual E; Zeuli M; Paoletti G; Garufi C; Cosimelli M;
    In Vivo; 2006; 20(6A):711-4. PubMed ID: 17203751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of advanced neuroendocrine tumors with hepatic metastasis.
    Khasraw M; Gill A; Harrington T; Pavlakis N; Modlin I
    J Clin Gastroenterol; 2009 Oct; 43(9):838-47. PubMed ID: 19654558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective Internal Radiation Therapy (SIRT) for liver metastases secondary to colorectal adenocarcinoma.
    Welsh JS; Kennedy AS; Thomadsen B
    Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S62-73. PubMed ID: 16979443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arterial therapies of non-colorectal cancer metastases to the liver (from chemoembolization to radioembolization).
    Hoffmann RT; Paprottka P; Jakobs TF; Trumm CG; Reiser MF
    Abdom Imaging; 2011 Dec; 36(6):671-6. PubMed ID: 21584635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoembolization of hepatic malignancies.
    Soulen MC
    Oncology (Williston Park); 1994 Apr; 8(4):77-84; discussion 84, 89-90 passim. PubMed ID: 8003400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver-directed therapies: does it make sense in the current therapeutic strategy for patients with confined liver colorectal metastases?
    Seront E; Van den Eynde M
    Clin Colorectal Cancer; 2012 Sep; 11(3):177-84. PubMed ID: 22306027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective internal radiation therapy (SIRT) with 90Yttrium microspheres for extensive colorectal liver metastases.
    Stubbs RS; Cannan RJ; Mitchell AW
    Hepatogastroenterology; 2001; 48(38):333-7. PubMed ID: 11379303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palliation of hepatic tumors.
    Cunningham SC; Choti MA; Bellavance EC; Pawlik TM
    Surg Oncol; 2007 Dec; 16(4):277-91. PubMed ID: 17935975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.